IPO Detail
Corona Remedies Limited
MAINBOARDNot investment advice. Read RHP before applying.
Price Band
₹1008 – ₹1062
GMP (Indicative)
₹300
Unofficial · not guaranteed
Lot Size
14 shares
Status
Listed
Open Date
2025-12-08
Close Date
2025-12-10
Listing Date
2025-12-15
Min. Investment
₹14,868
Overview
About the Company
Corona Remedies Limited is an Indian pharmaceutical company engaged in the development, manufacturing, and marketing of branded formulations. The company focuses on therapeutic segments such as women's healthcare, cardiology, pain management, and nutraceuticals. It operates through a strong field force and manufacturing facilities across India.
New to IPO analysis? You may review our structured guides on how IPO allotment works and IPO subscription meaning to better understand demand and allocation mechanics.
Financials
Key Financial Metrics
EPS Pre IPO
24.43
EPS Post IPO
24.43
P/E Pre
41.26
P/E Post
43.47
ROCE
41.32%
Debt / Equity
0.1
PAT Margin
20.55%
Market Cap
655.37
Financial figures sourced from official offer documents. Always verify with the RHP.
Issue
IPO Issue Details
Issue Price
₹1008 – ₹1062
Face Value
₹10
Issue Size
655.37
Fresh Issue
0
Listing At
BSE,NSE
Lead Manager
JM Financial Limited IIFL Capital Services Limited Kotak Mahindra Capital Company Limited
Registrar
Bigshare Services Private Limited
Lot Size
14
For category-wise quota breakdown such as QIB, HNI, and Retail allocation, refer to our IPO quota structure explanation.
Investors
Anchor Investors
Various domestic and international institutional investors participated as anchor investors prior to the IPO opening.
GMP (Grey Market Premium)
GMP Overview
₹300
Updated —
+28.2% over issue price
GMP is unofficial and indicative only. It does not guarantee listing price or returns.
GMP is unofficial and indicative. To understand interpretation logic and limitations, read our IPO Grey Market Guide or begin with what IPO GMP means.
Trend
GMP Trend
No GMP data yet. Updates will appear once available.
Investment
Market Lot Details
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 14 | 14868 |
| Retail (Max) | 13 | 182 | 193284 |
| sNII (Min) | — | — | — |
| bNII (Min) | — | — | — |
| sNII (Max) | 66 | 924 | 981288 |
| bNII (Max) | — | — | — |
Investors can bid in multiples of the lot size. Final investment depends on the cutoff price.
Valuation
IPO Valuation Metrics
EPS Pre IPO
24.43
EPS Post IPO
24.43
P/E Pre
41.26
P/E Post
43.47
ROCE
41.32%
Debt/Equity
0.1
RoNW
—
PAT Margin
20.55%
Market Cap
655.37
Contacts
Company & Registrar Details
Company Address: Corona Remedies Limited Ahmedabad, Gujarat, India
Phone: +91 79 2642 3155
Email: info@coronaremedies.com
Website: https://www.coronaremedies.com
Registrar: Bigshare Services Private Limited
Registrar Phone: +91 22 6263 8200
Registrar Email: ipo@bigshareonline.com
Registrar Website: https://www.bigshareonline.com
Issue Summary
Objectives of Issue
The IPO is entirely an Offer For Sale (OFS). The proceeds will go to the existing shareholders selling their stake and the company will not receive any fresh capital from the issue.
Ownership
Promoter Holdings
Pre Issue
100%
Post Issue
74.36%
Allocation
Reservation Details
QIB
50
NII
15
RII
35
Employee
0
Documents
Important Links
Performance
Listing Performance
Listing Exchange
BSE,NSE
Listing Price
₹1,470
Listing Gain
38.4180790960452%
Qualitative Factors
Strengths & Risks
Company Strengths
Strong branded pharmaceutical portfolio Wide distribution network across India Focused therapeutic segments with high growth potential Established relationships with healthcare professionals Consistent financial performance with low debt
Company Risks
High competition in pharmaceutical formulations Dependence on regulatory approvals for drugs Pricing pressure due to government regulations Dependence on domestic pharmaceutical market
Schedule
Timeline
Open Date
2025-12-08
Close Date
2025-12-10
Allotment Date
2025-12-11
Refund Date
2025-12-12
Listing Date
2025-12-15
Legal Disclaimer
Information is sourced from publicly available exchange filings and company offer documents. GMP is unofficial and indicative. IPOCraft does not provide investment advice.
Subscription
Live Subscription Details
| Day | QIB | NII | sNII (< ₹10L) | bNII (> ₹10L) | Retail | Total |
|---|---|---|---|---|---|---|
| 10-12-2025 | 293x | 220.18x | 167.2x | 246.67x | 30.39x | 144.54x |
Subscription Progress
Subscription data sourced from exchange updates. Values represent times subscribed (x).
Learn how subscription categories are allocated by reading our guide on QIB, HNI and Retail IPO quota structure.
If you are tracking GMP alongside subscription demand, see our grey market premium guide for a structured comparison framework.
Application
How to Apply
UPI Method (ASBA)
Log in to your broker's app or net banking, navigate to the IPO section, select this IPO, enter lot quantity, and authorise via UPI mandate. Funds are blocked, not debited, until allotment.
ASBA via Net Banking
Log in to your bank's net banking portal, go to the IPO / ASBA section, fill in the bid details, and submit. Your bank will block the required amount automatically.
Allotment & Refund
Allotment status is typically available within 6 days of the IPO close date. Refunds for unallotted bids are credited within 2 working days post allotment.
You may also review the complete IPO allotment process explanation to understand lottery mechanics and refund timelines.
Risk Disclosure
Investments in IPOs are subject to market risks. Grey Market Premium (GMP) is unofficial and indicative only — it does not guarantee listing price or returns. Read the official offer documents (DRHP / RHP) and consult a SEBI-registered financial advisor before applying. IPOCraft does not provide investment advice.
Research Before You Apply